Canada markets closed

Simcere Pharmaceutical Group Ltd (S2P.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.6350+0.0050 (+0.79%)
At close: 11:41AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
6,607,805
6,607,805
6,324,082
4,999,718
4,508,720
Cost of Revenue
1,623,652
1,623,652
1,327,404
1,079,983
899,927
Gross Profit
4,984,153
4,984,153
4,996,678
3,919,735
3,608,793
Operating Expenses
Research Development
1,563,138
1,563,138
1,728,283
1,416,721
1,141,996
Selling General and Administrative
2,844,215
2,844,215
2,842,158
2,395,525
1,978,480
Total Operating Expenses
4,257,652
4,257,652
4,422,047
3,687,923
3,018,910
Operating Income or Loss
726,501
726,501
574,631
231,812
589,883
Interest Expense
34,568
34,568
34,408
70,848
133,729
Income Before Tax
740,038
740,038
886,254
1,401,797
805,088
Income Tax Expense
26,088
26,088
-40,478
-97,124
140,801
Income from Continuing Operations
713,950
713,950
926,732
1,498,921
664,287
Net Income
714,761
714,761
930,868
1,507,096
669,534
Net Income available to common shareholders
714,761
714,761
930,868
1,507,096
669,534
Basic EPS
1.21
-
0.36
0.58
0.26
Diluted EPS
1.20
-
0.36
0.58
0.26
Basic Average Shares
2,616,326
-
2,611,172
2,608,642
2,608,642
Diluted Average Shares
2,626,069
-
2,620,376
2,611,358
2,608,642